38719, document 2026-12937), pushing the deadline to July 30, 2026 As of this article's July 2026 review date, the comment period was still open and FDA had not announced a final determination You can follow the docket directly at either link above rather than relying on this article's summary of it
In a healthy system, the body seamlessly shifts between burning carbohydrates and fats depending on immediate energy needs and postural demands
Regarding weight loss, the FDA has approved these drugs for people whose body mass index (BMI) is greater than 30 kg/m2, or they have a BMI that is greater than 27 and have a weight-related health problem, such as high blood pressure, sleep apnea, or pre-diabetes
Does the PlexusDx Precision Peptide Genetic Test show whether I'll tolerate alcohol better on GLP-1s
Placing ice between cheek and gum can reduce erythema short-term
Personalized Care: Every treatment plan is customized to address your unique skin concerns and goals